Synapse - Works

Results (607)

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: A report from the Children's Cancer Group

Journal Article

Heerema, N. A.; Nachman, J. B.; Sather, H. N.; La, M. K.; Hutchinson, R.; Lange, B. J.; Bostrom, B.; Steinherz, P. G.; Gaynon, P. S.; Uckun, F. M.
Leukemia (2004)

Fulltext@MSK | Save

Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia

Journal Article

Bonate, P. L.; Craig, A.; Gaynon, P.; Gandhi, V.; Jeha, S.; Kadota, R.; Lam, G. N.; Plunkett, W.; Razzouk, B.; Rytting, M.; more...
Journal of Clinical Pharmacology (2004)

Fulltext@MSK | Save

A multicenter phase 1 dose escalation study of DX-8951F administered daily for five days every three weeks in advanced pediatric solid tumors

Meeting Abstract

Trippett, T. M.
Clinical Cancer Research (2003)

Fulltext@MSK | Save

Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis

Meeting Abstract

Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
Blood (2003)

Fulltext@MSK | Save

A phase II, open-label study of clofarabine in pediatric patients with refractory or relapsed acute myelogenous leukemia

Meeting Abstract

Jeha, S.; Steinherz, P.; Gaynon, P.; Rheingold, S.; Razzouk, B.; Ritchey, A. K.; Altman, A.; Albano, E.; Stine, K.; Chan, K. W.; more...
Blood (2003)

Fulltext@MSK | Save

A phase II, open-label study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Meeting Abstract

Jeha, S.; Gaynon, P.; Steinherz, P.; Kadota, R.; Bomgaars, L.; Razzouk, B.; Luchtman-Jones, L.; Altman, A.; Rheingold, S.; Ritchey, A. K.; more...
Blood (2003)

Fulltext@MSK | Save

Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)

Meeting Abstract

Boulad, F.; Steinherz, P. G.; Kernan, N. A.; Small, T. N.; Prasad, V. K.; Prockop, S. E.; Kolb, A.; O'Reilly, R. J.
Blood (2003)

Fulltext@MSK | Save

Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: A Children's Cancer Group study

Journal Article

Levy, A. S.; Sather, H. N.; Steinherz, P. G.; Sowers, R.; La, M.; Moscow, J. A.; Gaynon, P. S.; Uckun, F. M.; Bertino, J. R.; Gorlick, R.
Journal of Pediatric Hematology/Oncology (2003)

Fulltext@MSK | Save

A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia

Journal Article

Kolb, E. A.; Steinherz, P. G.
Leukemia (2003)

Fulltext@MSK | Save

Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood

Journal Article

Kolb, E. A.; Pan, Q.; Ladanyi, M.; Steinherz, P. G.
Cancer (2003)

Fulltext@MSK | Save